How many employees does Elan have this year?
Elan has 290 undefined employees this year.
Elan Employees 2025
Elan Employees
290
Ticker
6099.T
ISIN
JP3167680002
WKN
A12C13
In 2025, Elan employed 290 people, a 0% change from the 290 number of employees in the previous year.
Elan Aktienanalyse
What does Elan do?
Elan Corp is an Irish pharmaceutical company specializing in the research, development, and marketing of medications for neurological and autoimmune diseases. The company was founded in 1969 under the name Athlone Laboratories and has since undergone significant changes in both its business fields and its name. In 1996, the company was renamed Elan Corporation, a name it still holds today. At that time, the company primarily focused on researching and developing medications for Alzheimer's and Parkinson's diseases. However, in the following years, the company shifted its focus more towards treating autoimmune diseases such as multiple sclerosis and Crohn's disease. Elan Corp's business model is based on the development of medications through research and development as well as the acquisition of established therapeutics. One key component of the product portfolio is the medication Tysabri, which was developed in collaboration with Biogen Idec. It is used to treat multiple sclerosis patients and is one of Elan's top-selling medications, contributing significantly to the company's success. Elan Corp consists of three main business areas: 1. Biopharmaceuticals This division is responsible for the research and development of medications for neurological diseases such as Alzheimer's, Parkinson's, and multiple sclerosis. Some of the key products in this area, in addition to Tysabri, include Axona, a nutritional supplement to enhance cognitive function in Alzheimer's patients, and Zanaflex, which is used to treat muscle spasms in the majority of multiple sclerosis patients. 2. Neurology In this division, Elan focuses on the marketing and distribution of nerve and pain medications, as well as products for treating infections. Some of the key products in this area are Skelaxin, a muscle relaxant for pain and muscle spasms, and Biaxin, an antibiotic for treating infections. 3. Medical Technology Elan Corp's medical technology division specializes in the development and marketing of infusion pumps. The company primarily offers its products and services in the United States and Europe and holds a strong position in this market. Elan Corp is a company with a strong focus on research and development. Its key products are medications for treating neurological and autoimmune diseases, with Tysabri being the most well-known and successful. The company has undergone significant changes over the years and now focuses on developing medications for autoimmune diseases in the neurology field. With a strong emphasis on research and development, as well as the acquisition of established therapeutics, Elan Corp is an important player in the pharmaceutical industry and is expected to continue growing and succeeding in the future. Elan ist eines der beliebtesten Unternehmen auf Eulerpool.com.Employees Details
Examining Elan's Employee Base
Elan's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Elan's operational capacity and future potential.
Year-to-Year Comparison
Assessing Elan's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.
Impact on Investments
Elan's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.
Interpreting Employee Trends
Fluctuations in Elan’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.
Frequently Asked Questions about Elan stock
How many employees did Elan have compared to the previous year?
Compared to the previous year, Elan had 0% more employees.
What impact did the number of employees have on the company Elan?
The number of employees has a direct impact on the efficiency and productivity of Elan. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.
What impact did the number of employees have on investors of Elan?
The number of employees can also have an impact on investors of Elan, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.
How does an increase in equity capital of Elan affect the company?
An increase in equity of Elan can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.
How does a reduction in Elan's equity affect the company?
A reduction in equity of Elan can impair its financial stability and decrease its ability to fulfill future investments and obligations.
What are some factors that influence the equity of Elan?
Some factors that can influence the equity of Elan include, among others, revenue development, profit and loss statement, dividend payments, and investments.
Why is the equity of Elan so important for investors?
The equity of Elan is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.
How does the number of employees at Elan influence the company?
The number of employees at Elan can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.
How has the number of employees at Elan evolved in recent years?
In recent years, the number of employees at Elan has changed by 0.
How many employees does Elan currently have?
Elan currently has 290 undefined employees.
Why is the number of employees important for investors of Elan?
The number of employees is important for investors of Elan as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.
What strategic measures can Elan take to change the number of employees?
To change the number of employees, Elan can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.
How much dividend does Elan pay?
Over the past 12 months, Elan paid a dividend of 13 JPY . This corresponds to a dividend yield of about 1.77 %. For the coming 12 months, Elan is expected to pay a dividend of 15.1 JPY.
What is the dividend yield of Elan?
The current dividend yield of Elan is 1.77 %.
When does Elan pay dividends?
Elan pays a quarterly dividend. This is distributed in the months of January, January, January, January.
How secure is the dividend of Elan?
Elan paid dividends every year for the past 13 years.
What is the dividend of Elan?
For the upcoming 12 months, dividends amounting to 15.1 JPY are expected. This corresponds to a dividend yield of 2.05 %.
In which sector is Elan located?
Elan is assigned to the 'Health' sector.
Wann musste ich die Aktien von Elan kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Elan from 3/1/2025 amounting to 14 JPY, you needed to have the stock in your portfolio before the ex-date on 12/27/2024.
When did Elan pay the last dividend?
The last dividend was paid out on 3/1/2025.
What was the dividend of Elan in the year 2024?
In the year 2024, Elan distributed 13 JPY as dividends.
In which currency does Elan pay out the dividend?
The dividends of Elan are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Elan
Our stock analysis for Elan Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Elan Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
